Exodus Point Capital Management, LP Centessa Pharmaceuticals PLC Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 379,314 shares of CNTA stock, worth $3.76 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
379,314Holding current value
$3.76 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
73Shares Held
84.5MCall Options Held
17.7KPut Options Held
5K-
Medicxi Ventures Management (Jersey) LTD20MShares$198 Million59.15% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$98.6 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$95.8 Million2.56% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.62MShares$55.6 Million1.81% of portfolio
-
Vida Ventures Advisors, LLC3.93MShares$38.9 Million61.75% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $934M
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...